OKYO Pharma to Present at the Second Annual GPCRs-Targeted Drug Discovery Summit in Boston, MA on February 21-23, 2023.
21 févr. 2023 07h00 HE
|
OKYO Pharma LTD
LONDON and NEW YORK, Feb. 21, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO) (“OKYO”, “OKYO Pharma” or the “Company”), an ophthalmology-focused bio-pharmaceutical company...
PharmAla Named Exclusive MDMA Supplier to Revive Therapeutics
06 févr. 2023 08h00 HE
|
PharmAla Biotech
VANCOUVER, British Columbia, Feb. 06, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) is pleased to announce that it has signed on to act as exclusive supplier of...
Australia Allows Prescription of MDMA and Psilocybin in Groundbreaking Regulatory Change
03 févr. 2023 00h01 HE
|
PharmAla Biotech
VANCOUVER, British Columbia, Feb. 03, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) applauds the Australian Therapeutic Goods Administration (TGA) in allowing for...
Gravity Diagnostics Receives Accreditation From the College of American Pathologists
02 févr. 2023 09h35 HE
|
Gravity Diagnostics
Covington, Kentucky, Feb. 02, 2023 (GLOBE NEWSWIRE) -- The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to Gravity Diagnostics based on the results...
PharmAla Biotech granted an Export Permit for 300 grams of LaNeo™ MDMA
24 janv. 2023 08h50 HE
|
PharmAla Biotech
VANCOUVER, British Columbia, Jan. 24, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”) (CSE: MDMA), a biotechnology company focused on the research, development, and...
7 Mindsets Acquires BASE Education
18 janv. 2023 09h30 HE
|
7 Mindsets
ROSWELL, Ga., Jan. 18, 2023 (GLOBE NEWSWIRE) -- 7 Mindsets, the leader in PreK-12 mindsets-based learning and well-being solutions, today announced the acquisition of BASE Education, a student...
Indegene expands Europe presence with new center in Germany to enable life sciences companies be future ready
10 janv. 2023 07h30 HE
|
Indegene Inc
FRANKFURT, Germany and PRINCETON, N.J. and BANGALORE, India, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Indegene, a digital-first, life sciences commercialization company, today announced the launch of a new...
Imbria Enrolls First Patient in the Phase 2 IMPROVE-DiCE Clinical Trial Evaluating Ninerafaxstat in Patients with Heart Failure with Preserved Ejection Fraction
09 janv. 2023 08h00 HE
|
Imbria Pharmaceuticals Inc.
BOSTON, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company developing novel therapies designed to enhance cellular energetics, today announced...
Gravity Diagnostics Announces New Director of Compliance
21 déc. 2022 09h04 HE
|
Gravity Diagnostics
Covington, Kentucky, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Gravity Diagnostics, a CAP-accredited, CLIA-certified laboratory licensed in all 50 states, has officially welcomed Erica Adams as their...
Mindset Pharma and PharmAla Biotech Enter into Exclusive Sales Agreement
16 nov. 2022 07h30 HE
|
PharmAla Biotech
VANCOUVER, British Columbia, Nov. 16, 2022 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA), a biotechnology company focused on the research, development, and manufacturing...